Русский
English
عربي
Egyphar
Egyphar is committed to providing innovative products and services that save and improve lives, ensuring they are affordable to a broad segment of the population. The company's vision is to transform into a healthcare leader by enhancing innovation in research and development, focusing on patient needs, and improving quality of life through effective decision-making processes
Manufacturing Capabilities:
Egyphar operates a manufacturing plant established in 2007, specializing in the production of human medicines and adhering to Good Manufacturing Practice (GMP) standards set by the World Health Organization (WHO). The plant includes production lines for solid dosage forms (tablets, hard gelatin capsules, and powder for oral suspension), liquid dosage forms (syrups for oral use), and soft gelatin capsules. Plans are underway to establish a second manufacturing plant by 2021 to significantly increase production capacity.
Brand products
